logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Rheumatoid Arthritis

    FiltersReset Filters
    168 results

    • abrilada

      (adalimumab-afzb)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ABRILADA is indicated for the treatment of various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and certain pediatric patients.

    • abrilada

      (adalimumab-afzb)
      Pfizer Laboratories Div Pfizer Inc
      Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients.

    • actemra

      (tocilizumab)
      Genentech, Inc.
      Usage: ACTEMRA (tocilizumab) is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis, severe cytokine release syndrome, and COVID-19 in hospitalized adults receiving systemic corticosteroids.

    • acthar

      (Repository Corticotropin)
      Mallinckrodt ARD LLC
      Usage: Acthar Gel is indicated for treating infantile spasms in infants, acute exacerbations of multiple sclerosis in adults, and various rheumatic disorders. It is also used for collagen diseases, severe dermatologic conditions, allergic states, specific ophthalmic and respiratory diseases, and to manage proteinuria in nephrotic syndrome.

    • adalimumab

      (adalimumab-fkjp)
      Biocon Biologics Inc
      Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).

    • adalimumab-ryvk

      (adalimumab-ryvk)
      Quallent Pharmaceuticals Health LLC
      Usage: Adalimumab-ryvk is indicated for the treatment of moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in patients ages 2 and older.

    • amjevita

      (adalimumab-atto)
      Optum Health Solutions (Ireland) Limited
      Usage: AMJEVITA is indicated for various autoimmune conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, to reduce symptoms and improve functionality.

    • azathioprine

      (Azathioprine)
      AvKARE
      Usage: Azathioprine tablets are indicated for preventing rejection in renal transplants and managing active rheumatoid arthritis to reduce symptoms. It may be used alongside certain medications, but combined use with DMARDs has not been studied. Patient survival outcomes in transplants vary based on several factors.

    • azathioprine

      (Azathioprine)
      Amneal Pharmaceuticals NY LLC
      Usage: Azathioprine tablets are indicated to prevent rejection in renal homotransplantation and to manage active rheumatoid arthritis, reducing its signs and symptoms. Caution is advised when combining with other disease-modifying anti-rheumatic drugs, as their combined effects have not been studied.

    • azathioprine

      (Azathioprine)
      Ascend Laboratories, LLC
      Usage: Azathioprine is indicated as an adjunct for preventing rejection in renal homotransplantation and for managing active rheumatoid arthritis to reduce signs and symptoms. Its combined use with other disease-modifying anti-rheumatic drugs has not been studied and is not recommended.
      • ...